Synapse Biomedical’s Diaphragm Pacing System Gets FDA Premarket Approval
The FDA granted premarket approval of Synapse Biomedical's NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries.
The FDA granted premarket approval of Synapse Biomedical's NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries.
The FDA granted premarket approval of Synapse Biomedical's NeuRx Diaphragm Pacing System for use in patients with spinal cord injuries.